It can be inferred from the above that NE may ameliorate dyslipidemia, memory impairment, and cognitive dysfunction in diabetic mice by inhibiting ERS-induced TXNIP/NLRP3 inflammasome, which provides a treatment strategy for diabetic encephalopathy. Here, NLRP3 is linked to diabetic encephalopathy.